Anti-SAE dermatomyositis
MONDO:1010088A dermatomyositis characterized by the presence of anti-SAE autoantibodies.
Also known as: anti-small ubiquitin-like modifier activating enzyme dermatomyositis
12 clinical trials for this condition and its sub-types, 0 tagged with Anti-SAE dermatomyositis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Immune system overhaul: could CAR T-Cells tame autoimmune disease?
Disease control OngoingThis early-stage trial is testing a new treatment called KYV-101 for people with severe autoimmune diseases like lupus, scleroderma, and vasculitis. The treatment involves taking a patient's own immune cells, modifying them to target and destroy faulty B cells, and giving them ba…
Phase 1 • Sponsor: David Porter • Aim: Disease control
Last updated Sep 21, 2026 14:00 UTC
-
New pill could ease rare muscle disease symptoms
Disease control CancelledThis study is testing a drug called deucravacitinib in 10 adults with idiopathic inflammatory myopathies, a group of rare diseases that cause muscle inflammation and weakness. Participants will take one pill daily for 6 months. Researchers will track symptom changes and lab resul…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC